Smoking Cessation Smartphone App for Cancer Patients (Quit2Heal Study) (Quit2Heal)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03600038|
Recruitment Status : Active, not recruiting
First Posted : July 25, 2018
Last Update Posted : April 4, 2019
|Condition or disease||Intervention/treatment||Phase|
|Cancer Smoking||Behavioral: Experimental smoking cessation smartphone app Behavioral: Standard of care smoking cessation smartphone app||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||66 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||Pilot Trial of a Smartphone Smoking Cessation Application Intervention for Cancer Patients (Quit2Heal Study)|
|Actual Study Start Date :||April 2, 2018|
|Estimated Primary Completion Date :||July 2019|
|Estimated Study Completion Date :||December 2019|
This is the experimental arm of the study. This includes receiving the novel/experimental smoking cessation smartphone app. Therapy description of experimental app withheld to protect the integrity of the study.
Behavioral: Experimental smoking cessation smartphone app
The experimental arm includes an intervention using a novel/experimental smartphone smoking cessation app.
Active Comparator: Control
This is the control arm of the study. This includes receiving the standard of care smoking cessation smartphone app. Therapy description of standard of care app withheld to protect the integrity of the study.
Behavioral: Standard of care smoking cessation smartphone app
The control intervention uses a standard of care smartphone smoking cessation app.
- 30-day point prevalence abstinence [ Time Frame: 2 months post randomization ]No smoking in the past 30 days, as reported 2 months post treatment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03600038
|United States, Washington|
|Fred Hutchinson Cancer Research Center|
|Seattle, Washington, United States, 98109|